NASDAQ:ALXO
ALX Oncology Holdings Inc.
- Stock
locale
United Statesmarket
STOCKSindustry
Biotechnologywebsite
www.alxoncology.comcrunchbase
alexo-therapeutics-limitedipo date
Jul 17, 2020
ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hodgkin's lymphoma, as well as a ran...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus